Save
Share
Joy Linton wants to make something crystal clear: the AstraZeneca vaccine is a workhorse jab that is highly effective and saving millions of lives across the world.
She speaks with some authority â and no little interest â as the new chief financial officer of Melbourne-based biotech giant CSL, which makes the controversial vaccine in Australia.
CSLâs new CFO, Joy Linton, joined the biotech in March, working from hotel quarantine for her first few weeks on the job. Â
Tash Sorensen
Linton moved back home in March after more than six years in London, where the COVID-19 pandemic raged out of control, and spent the first few weeks of her new job in hotel quarantine.